Browse drugs

…presented in table 2. 98% used stimulant drugs, most frequently MDPV (77%). While clients most frequently practiced chemsex weekly (…

…sions In the PrIDE cohort, bacterial STIs remain frequent among PrEP users, with a substantial burden of early and recurrent events,…

…up vs. 75 (62.5%) in SD group. 4/120 were previously exposed to PrEP (3 in SD vs. 1 in RS). At baseline, 3/119 had HCV antibodies (a…

…als underwent screening. In contrast, pre-exposure prophylaxis (PrEP) users and individuals with a history of sexually transmitted i…

… prophylaxis (PEP), and none reported pre-exposure prophylaxis (PrEP) use prior to diagnosis. Among newly diagnosed individuals, the…

…d gaining new knowledge about HIV and pre-exposure prophylaxis (PrEP) from the chatbot that made them consider their own HIV vulnera…

…d HIV infection. Stakeholders in healthcare should promote oral PrEP interventions and design programmes for HIV prevention among wo…

… to have high rates of HIV infection. Pre-exposure prophylaxis (PrEP) is an effective treatment that, when taken as prescribed, can …

…th pathways may improve access to HIV-pre-exposure prophylaxis (PrEP) for some people.1 PrEP-EmERGE, a co-designed digital pathway d…

…ing pre-exposure prophylaxis (PrEP) to prevent HIV acquisition (PrEP need), and of these, the number who did not access PrEP (unmet …

…Introduction Oral HIV pre-exposure prophylaxis (PrEP) is a highly effective biomedical intervention for HIV preventi…